TPCW
COLL icon

TD Private Client Wealth’s Collegium Pharmaceutical COLL Stock Holding History

TD Private Client Wealth’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$74K Buy
2,239
+232
+12% +$9.82K ﹤0.01% 811
2025
Q4 		$92.9K Hold
2,007
– – ﹤0.01% 775
2025
Q3 		$70.2K Hold
2,007
– – ﹤0.01% 804
2025
Q2 		$59.3K Hold
2,007
– – ﹤0.01% 817
2025
Q1 		$59.9K Hold
2,007
– – ﹤0.01% 780
2024
Q4 		$57.5K Buy
2,007
+300
+18% +$9.93K ﹤0.01% 795
2024
Q3 		$66K Buy
1,707
+483
+39% +$17.2K ﹤0.01% 782
2024
Q2 		$39.4K Buy
1,224
+341
+39% +$11.8K ﹤0.01% 853
2024
Q1 		$34.3K Buy
+883
New +$30.9K ﹤0.01% 878

Other funds holding COLL

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return